Jefferies has initiated Krystal Biotech at buy citing growth in sales of Vyjuvek (beremagene geperpavec), a gene therapy for a rare skin condition, as well as its in-house gene delivery technology.
The European Medicines Agency’s (EMA) human medicines committee has recommended Krystal Biotech’s Vyjuvek (beremagene geperpavec) to treat patients with the ultra-rare genetic blistering disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback